CYCLOBENZAPRINE ER 30 MG CAP

What it is

CYCLOBENZAPRINE ER 30 MG CAP is how the CMS NADAC file names this product. The FDA NDC Directory lists it as cyclobenzaprine hydrochloride.

FDA gives its dosage form as capsule, extended release and its route as oral.

Its labelers, the companies named on the label, are Teva Pharmaceuticals USA, Inc., Amneal Pharmaceuticals of New York LLC and Upsher-Smith Laboratories, LLC.

FDA’s Established Pharmacologic Class for it is Muscle Relaxant.

The NADAC file of 2026-10-14 prices it under 3 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $32.47 for 30 capsules (30 × $1.0822 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 1, calculated from the most recently completed pharmacy survey; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

What NADAC measures · Why 30 capsules · NADAC explanation codes

All 3 NDCs

• 00093-1921-06 · Teva Pharmaceuticals USA, Inc. · $1.0822 per EA · eff. 2026-09-23 filed
• 00115-1437-13 · Amneal Pharmaceuticals of New York LLC · $1.0822 per EA · eff. 2026-09-23 filed
• 24979-0036-04 · Upsher-Smith Laboratories, LLC · $1.0822 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

8 other products in the NADAC file share the FDA nonproprietary name cyclobenzaprine hydrochloride with CYCLOBENZAPRINE ER 30 MG CAP.

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-01-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 3 NDCs’ NADAC prices is $1.0822 per EA filed.

Of the 22 other products in FDA’s Muscle Relaxant class priced per EA, 9 have a higher middle NADAC price and 13 a lower one. The one in the middle is CARISOPRODOL 250 MG TABLET, at $0.47389 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

How the class comparison works

What Medicare paid

We don’t know yet; the card above says why.

Which Medicare figure OpenBill compares · How Part D is matched · How Part B is matched

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

• What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
• These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.